1. Home
  2. Labeler Index
  3. Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc
  4. 58394-095
  5. NDC Package Code: 58394-095-05 Bevacizumab

NDC Package 58394-095-05 Bevacizumab

Liquid - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
58394-095-05
Package Description:
95.5 mL in 1 CONTAINER
Product Code:
58394-095
Non-Proprietary Name:
Bevacizumab
Substance Name:
Bevacizumab
Usage Information:
This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.
11-Digit NDC Billing Format:
58394009505
Product Type:
Drug For Further Processing
Labeler Name:
Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s):
  • BEVACIZUMAB 95.5 mg/95.5mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    09-19-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 58394-095-05?

    The NDC Packaged Code 58394-095-05 is assigned to an UNFINISHED drug package of 95.5 ml in 1 container of Bevacizumab, drug for further processing labeled by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc. The product's dosage form is liquid and is administered via form.

    Is NDC 58394-095 included in the NDC Directory?

    Yes, Bevacizumab is an UNFINISHED PRODUCT with code 58394-095 that is active and included in the NDC Directory. The product was first marketed by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc on September 19, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 58394-095-05?

    The 11-digit format is 58394009505. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-258394-095-055-4-258394-0095-05